BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kapacee ZA, Mcnamara MG, de Liguori Carino N, Lamarca A, Valle JW, Hubner RA. Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare? European Journal of Surgical Oncology 2021;47:583-90. [DOI: 10.1016/j.ejso.2020.03.210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wilhelmi M. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine. Eur J Surg Oncol 2021;47:2208. [PMID: 33906788 DOI: 10.1016/j.ejso.2021.04.014] [Reference Citation Analysis]
2 Kamioka H, Edaki K, Kasahara H, Tomono T, Yano K, Ogihara T. Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells. J Pharm Pharmacol 2021:rgab051. [PMID: 34313784 DOI: 10.1093/jpp/rgab051] [Reference Citation Analysis]
3 Macias RIR, Monte MJ, Serrano MA, González-Santiago JM, Martín-Arribas I, Simão AL, Castro RE, González-Gallego J, Mauriz JL, Marin JJG. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging (Albany NY) 2021;13:23416-34. [PMID: 34633987 DOI: 10.18632/aging.203620] [Reference Citation Analysis]